Altogether, these data indicate that HIV-1 entry inhibitors are less efficient, in vitro, to block cell-to-cell virus transmission than cell-free HIV-1 infection of PBMCs and that CCR5 antagonists do not prevent PBMC infection by dual tropic HIV-1 in contrast to cell-to-cell infection in our model. The gene discussed is CCR5; the disease is HIV-1 infection.